AI-Led Diabetes Prevention Program as an Effective Alternative to Human Coaching: JAMA Dr Riya Dave24 Dec 2025 8:45 AM ISTResearchers have found in a new study that among adults with prediabetes and overweight or obesity, a fully automated, AI-led Diabetes Prevention...
SGLT-2 Inhibitors Have Neutral Impact on Incidence of Diabetic Retinopathy Risk: Study Finds Medha Baranwal23 Dec 2025 11:15 AM ISTSpain: Researchers have found in a new study that sodium-glucose cotransporter-2 (SGLT-2) inhibitors have a neutral effect on the incidence of...
Natural Light Exposure Improves Blood Glucose Control in Type 2 Diabetes: Study Dr Riya Dave23 Dec 2025 9:30 AM ISTA study published in Cell Metabolism has found that exposure to natural daylight through windows significantly improved glycemic control in people...
Low-dose aspirin linked to lower cardiovascular event risk for adults with Type 2 diabetes: Study Dr. Kamal Kant Kohli22 Dec 2025 8:30 PM ISTPeople with Type 2 diabetes (T2D) and an elevated risk for cardiovascular disease (CVD) who took low-dose aspirin were less likely to experience a...
Tirzepatide Matches Dulaglutide for Cardiovascular Protection With Added Metabolic Benefits: NEJM Dr Riya Dave22 Dec 2025 11:00 AM ISTIn a large randomized trial involving patients with type 2 diabetes and established atherosclerotic cardiovascular disease, tirzepatide was...
Unilateral Adrenalectomy Raises Long-Term CKD and Gout Risk in Primary Aldosteronism: Study Medha Baranwal21 Dec 2025 8:45 PM ISTTaiwan: A 20-year population study has revealed that patients with primary aldosteronism who undergo unilateral adrenalectomy face increased long-term...
Worsening Diabetes Complications Lower Quality of Life in Type 1 Diabetes, Suggests Study Medha Baranwal20 Dec 2025 9:30 AM ISTFrance: A study in Diabetes, Obesity and Metabolism found that adults with type 1 diabetes experienced a decline in health-related quality of life as...
ART Cycles Linked to Slight Increase in Cardiovascular Risk, Suggests Research Medha Baranwal20 Dec 2025 9:15 AM ISTNorway: Researchers have found in a new registry-based study that each additional cycle of assisted reproductive technology was associated with a...
Predicting who is at risk of developing type 1 diabetes, as new drugs now available: Lancet Dr. Kamal Kant Kohli20 Dec 2025 5:00 AM ISTA test using genetics to predict who is at the highest risk of developing type 1 diabetes could one day be applied to largescale health studies, to...
Semaglutide Significantly Improves Glycemia and Weight in Schizophrenia: JAMA Dr Riya Dave19 Dec 2025 8:45 PM ISTAccording to a new study published in JAMA Psychiatry, adjunctive semaglutide was shown to significantly improve glycemic control and weight outcomes...
World Health Organization Issues Guideline for Glucagon-like-Peptide-1 Therapies Use in Obesity: JAMA December 2025 Special Communication Dr. Bhumika Maikhuri19 Dec 2025 11:00 AM ISTA recent special communication highlighted that medication alone cannot solve the global obesity burden. The availability of GLP-1 therapies should...
GLP-1 Receptor Agonists Linked to Lower All-Cause Mortality in Hypertrophic Cardiomyopathy: AHJ, December 2025 Study Reveals New Cardiovascular Benefits Dr. Bhumika Maikhuri19 Dec 2025 10:30 AM ISTA recent study found that Glucagon-like peptide-1 (GLP-1) receptor agonist use in hypertrophic cardiomyopathy (HCM) patients with type 2 diabetes...
